Otrivine

Otrivine belongs to Haleon plc through GlaxoSmithKline Consumer Healthcare. Otrivine is owned by Haleon plc, headquartered in the United Kingdom. No. The ultimate owner of Otrivine, Haleon plc, is headquartered in the United Kingdom, not in the United States.

Bausch Health (formerly Valeant) is an international specialty pharmaceutical company that owns or licenses various over-the-counter and prescription brands globally. Some regional rights for nasal decongestant products are held or distributed by local pharmaceutical subsidiaries or licensees.

Local distributors or licensees vary by country; could be local pharmaceutical companies or subsidiaries (e.g., regional OTC distributors).